Abbott Laboratories is in talks to buy Exact Sciences, a company known for its Cologuard cancer test. Reports say the ...

Medical device maker Abbott Laboratories is nearing a potential takeover of cancer test maker Exact Sciences Corp, Bloomberg ...

As screening guidelines evolve and GI care increasingly shifts to outpatient settings, ASCs are seeing significant growth in colonoscopy volume. Here are ten developments shaping that trend: ...

Chinese researchers have developed a new sensor made of tiny microspheres packed with blood-sensing bacteria that detect ...

A biennial fecal immunochemical test-based CRC screening program can increase early-stage CRC detection and short-term survival.

Scientists have created swallowable microsphere “pills” packed with engineered bacteria that can detect signs of gut disease, ...

Move over, colonoscopies—researchers report in ACS Sensors that they've developed a sensor made of tiny microspheres packed ...

UCLA research finds that fewer than one in four eligible younger adults completed colorectal cancer screenings after the ...

NEW ULM – In 1984, Dr. Karl Papierniak came to New Ulm to practice as a general surgeon. He chose to practice in New Ulm ...

UCLA research finds that fewer than 1 in 4 eligible younger adults completed colorectal cancer screenings after the United States Preventive Services Task Force (USPSTF) lowered the recommended ...

All adverse outcomes were of mild or moderate severity, and no significant trends were observed on the basis of LVEF status. The most common adverse events were hypotension (33%-36.4%), arrhythmia ...

Jefferies London Healthcare Conference 2025 November 18, 2025 7:30 AM ESTCompany ParticipantsKevin Conroy - Chairman ...